Skip to main content
ASPN logo

ASPN · Aspen Aerogels Inc · Documents

Track ASPN — free
$4.87 -0.03 (-0.61%) Play latest call Q3 2026 earnings call transcript
Market Cap
$404.84M
Shares
83.13M
Volume · Nov 19 1.08M Avg daily vol (3M) 1.02M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $271.1M down 40.1% 10-K filed Mar 13, 2026 Quarterly report FY2026 Q3 Revenue $85.18M up 16.7% 10-Q filed Nov 5, 2026 Latest results Q3 revenue $85.2 million; Adjusted EBITDA $19.8 million 8-K filed Nov 5, 2026 Earnings call Q3 2026 earnings call Held Nov 5, 2026
2026
Nov 5
Registration statement S-3
Registers $150,000,000 Shelf for Future Offerings

Aspen Aerogels, Inc. is registering up to $150,000,000 of securities for future offerings from time to time. It intends to use any net proceeds for general corporate purposes, including working capital, capital expenditures, repayment of existing indebtedness, investments and acquisitions.

Read from the first part of this long document
3 source passages
Aspen Aerogels, Inc. Under this shelf registration process, we may from time to time offer shares of our common stock and preferred stock, various series of debt securities and/or warrants or rights to purchase any of such securities described in this prospectus, either individually or in units, in one or more offerings, for an aggregate offering amount of up to $150,000,000, at prices and on terms to be set forth in one or more supplements to this prospectus at the time of an offering. Unless otherwise indicated in the applicable prospectus supplement, we intend to use any net proceeds from the sale of securities under this prospectus for general corporate purposes, including, but not limited to, working capital, capital expenditures, repayment of any existing indebtedness, investments and acquisitions. Open the document at this passage
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises 17% while nine-month loss narrows

Aspen Aerogels reported third-quarter revenue of $85.2 million, up 17%, as energy industrial revenue rose 64% and thermal barrier revenue fell 7%. Nine-month revenue fell 25% to $172.9 million, while net loss improved to $57.4 million from $316.6 million.

Revenue $85.18M ▲ 16.7% Net loss $10.42M Diluted EPS -$0.13
Read from the MD&A section
4 source passages
Total revenue increased $12.2 million, or 17%, to $85.2 million for the three months ended September 30, 2026 from $73.0 million in the comparable period in 2025. Energy industrial revenue increased by $15.6 million, or 64%, to $39.9 million for the three months ended September 30, 2026 from $24.3 million in the comparable period in 2025. Thermal barrier revenue decreased by $3.4 million, or 7%, to $45.3 million for the three months ended September 30, 2026 from $48.7 million in the comparable period in 2025. Our revenue for the nine months ended September 30, 2026 was $172.9 million, which represented a decrease of $56.9 million, or 25%, from $229.8 million of revenue for the nine months ended September 30, 2025. Net loss for the nine months ended September 30, 2026 was $57.4 million and net loss per share was $0.69. Net loss for the nine months ended September 30, 2025 was $316.6 million and net loss per share was $3.85. Open the document at this passage
Nov 5
Earnings call
Profitability surges as first data center order lands

Aspen Aerogels reported Q3 2026 revenue of $85.2 million and adjusted EBITDA of $19.8 million, exceeding guidance. It secured its first data center infrastructure order and expects Q4 revenue of $60 to $75 million.

5 source passages
Aspen Aerogels Incorporated 3rd Quarter 2026 Financial Results Call. Third quarter revenue was $85.2 million, above the high end of our $65 to $80 million guidance range, and up 71% quarter-over-quarter, or 17% year-over-year. Adjusted EBITDA landed at $19.8 million, above our guidance range of $7 to $15 million. In a new adjacent market, we are pleased to have captured our first data center infrastructure order for delivery in Q4 2026. For the fourth quarter of 2026, we expect total revenue to be between $60 and $75 million. Open the document at this passage
Nov 5
Current report 8-K Events of Nov 2
Q3 revenue $85.2 million; Adjusted EBITDA $19.8 million

Aspen Aerogels reported third-quarter revenue of $85.2 million and Adjusted EBITDA of $19.8 million, alongside a $10.4 million net loss. It secured its first data center infrastructure order and expects Q4 2026 revenue of $60 million to $75 million.

Financial results, Director or officer change, or executive pay, Regulation FD disclosure
6 source passages
Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announced financial results for the third quarter of 2026, and discussed recent business developments. Total revenue for the third quarter of 2026 was $85.2 million, compared to $73.0 million in the prior year period. Net loss was $10.4 million, compared to net loss of $6.3 million in the prior year period. Adjusted EBITDA was $19.8 million, compared to $6.3 million in the prior year period. Received an initial Energy Industrial order for a data center infrastructure project, opening a new market opportunity, with delivery expected in the fourth quarter of 2026 Q4 2026 Revenue is expected to range between $60 million and $75 million Open the document at this passage
Aug 7
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $49.85M ▼ 36.1% Net loss $23.26M Diluted EPS -$0.28
May 8
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $37.88M ▼ 51.9% Net loss $23.69M Diluted EPS -$0.29
Mar 27
Proxy statement DEF 14A Meeting May 13, 2026
Proxy statement AI summary on its way
Mar 23
Annual report 10-K/A FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $271.1M ▼ 40.1% Net loss $389.55M Diluted EPS -$4.73
Mar 13
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $271.1M ▼ 40.1% Net loss $389.55M Diluted EPS -$4.73
Mar 13
Proxy statement PRE 14A Meeting May 13, 2026
Proxy statement AI summary on its way
2025
Feb 27
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $452.7M ▲ 89.6% Net income $13.38M Diluted EPS $0.17
2024
Showing 1–50 of 181 documents
Key facts CIK 1145986 CUSIP 04523Y105 13F (30d) 205 filings 181 filers Visit website Investor relations